80
54
Growth Score 80 in past quarter
-7 pts
Heat Score 54 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3398475
Hasbiotech is engaged in studies on drugs used for hematologic, metabolic and chronic diseases; oncology and wound treatment.
About the Company
Hasbiotech aim is to develop new alternatives to currently available treatment options; to investigate existing biotechnological and advanced treatment methods and bring them into use. Hasbiotech brings to Turkey many products from Cuba, a product that prevents the amputation in diabetic foot ulcers process Hasbiotech; continues to make significant
investments in drugs that will bring innovative solutions to diseases such as heart attack and Alzheimer's. Hasbiotech has also set its target on manufacturing an original Turkish medicine starting from scratch including raw materials.
